WeidnerTIllingTElsnerP. Primary localized cutaneous amyloidosis: a systematic treatment review. Am J Clin Dermatol. 2017;18(5):629-642. doi:10.1007/s40257-017-0278-9
2.
HumedaYBeasleyJCalderK. Clinical resolution of generalized lichen amyloidosis with dupilumab: a new alternative therapy. Dermatol Online J. 2020;26(12):18. doi:10.5070/D32612051364
3.
McCannMRKosloskiMPXuCDavisJDKamalMA. Dupilumab: Mechanism of action, clinical, and translational science. Clin Transl Sci. 2024;17(8):e13899. doi:10.1111/cts.13899
4.
TeyHLCaoTNattkemperLATanVWPramonoZAYosipovitchG. Pathophysiology of pruritus in primary localized cutaneous amyloidosis. Br J Dermatol. 2016;174(6):1345-1350. doi:10.1111/bjd.14391
5.
MiakeSTsujiGTakemuraM, et al. IL-4 augments IL-31/IL-31 receptor alpha interaction leading to enhanced Ccl 17 and Ccl 22 production in dendritic cells: implications for atopic dermatitis. Int J Mol Sci. 2019;20(16):4053. doi:10.3390/ijms20164053
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
